|
DE257197C
(enExample)
|
|
|
|
|
|
DE286509C
(enExample)
|
|
|
|
|
|
US3914252A
(en)
|
1971-03-15 |
1975-10-21 |
Continental Oil Co |
Preparation of N-iodocompounds
|
|
DD257197A1
(de)
|
1987-01-28 |
1988-06-08 |
Univ Dresden Tech |
Verfahren zur herstellung von immobilisierten, in ihrer biologischen aktivitaet stabilisierten und in ihren pharmakologischen eigenschaften modifizierten insulinpraeparationen
|
|
DK105489D0
(da)
|
1989-03-03 |
1989-03-03 |
Novo Nordisk As |
Polypeptid
|
|
DD286509A5
(de)
|
1989-06-30 |
1991-01-31 |
Veb Berlin-Chemie,De |
Verfahren zur herstellung von aktivitaetsstabilisierten, wirkungsverlaengerten rektal applizierbaren insulinpraeparationen
|
|
SE509359C2
(sv)
|
1989-08-01 |
1999-01-18 |
Cemu Bioteknik Ab |
Användning av stabiliserade protein- eller peptidkonjugat för framställning av ett läkemedel
|
|
ES2113940T3
(es)
|
1990-12-03 |
1998-05-16 |
Genentech Inc |
Metodo de enriquecimiento para variantes de proteinas con propiedades de union alteradas.
|
|
IL114160A
(en)
|
1994-06-17 |
2006-12-31 |
Novo Nordisk As |
Dna constructs encoding heterologous proteins and processes for the heterologous protein production in yeast
|
|
US6500645B1
(en)
|
1994-06-17 |
2002-12-31 |
Novo Nordisk A/S |
N-terminally extended proteins expressed in yeast
|
|
AU718439B2
(en)
|
1995-09-21 |
2000-04-13 |
Genentech Inc. |
Human growth hormone variants
|
|
AU5065198A
(en)
|
1996-11-15 |
1998-06-10 |
Maria Grazia Masucci |
Fusion proteins having increased half-lives
|
|
ES2258797T3
(es)
|
1996-12-20 |
2006-09-01 |
Novo Nordisk A/S |
Proteinas con extension n-terminal expresadas en la levadura.
|
|
CN1269805A
(zh)
|
1997-07-14 |
2000-10-11 |
博尔德生物技术公司 |
生长激素和相关蛋白的衍生物
|
|
ATE407697T1
(de)
|
1999-07-13 |
2008-09-15 |
Bolder Biotechnology Inc |
Erythropoietin immunglobulin fusionsproteine
|
|
US20050287153A1
(en)
|
2002-06-28 |
2005-12-29 |
Genentech, Inc. |
Serum albumin binding peptides for tumor targeting
|
|
US7608681B2
(en)
|
1999-12-24 |
2009-10-27 |
Genentech, Inc. |
Methods and compositions for prolonging elimination half-times of bioactive compounds
|
|
US20060183197A1
(en)
|
2001-01-11 |
2006-08-17 |
Andersen Kim V |
Variant growth hormone molecules conjugated with macromolecules compounds
|
|
WO2002055532A2
(en)
|
2001-01-11 |
2002-07-18 |
Maxygen Aps |
Variant growth hormone molecules conjugated with macromolecular compounds
|
|
PE20020908A1
(es)
|
2001-03-21 |
2002-10-26 |
Cell Therapeutics Inc |
Produccion recombinante de polimeros polianionicos y uso de de los mismos
|
|
US20050233417A1
(en)
|
2001-11-12 |
2005-10-20 |
Cooper David N |
Growth hormone variations in humans and their uses
|
|
GB2384001B
(en)
|
2001-12-14 |
2004-02-04 |
Asterion Ltd |
Chimeric growth hormone-growth hormone receptor proteins
|
|
WO2004029207A2
(en)
|
2002-09-27 |
2004-04-08 |
Xencor Inc. |
Optimized fc variants and methods for their generation
|
|
US20040180054A1
(en)
|
2003-03-13 |
2004-09-16 |
Hanmi Pharm. Co., Ltd. |
Physiologically active polypeptide conjugate having prolonged in vivo half-life
|
|
TWI353991B
(en)
|
2003-05-06 |
2011-12-11 |
Syntonix Pharmaceuticals Inc |
Immunoglobulin chimeric monomer-dimer hybrids
|
|
WO2005047337A1
(en)
|
2003-11-13 |
2005-05-26 |
Hanmi Pharmaceutical Co., Ltd. |
A pharmaceutical composition comprising an immunoglobulin fc region as a carrier
|
|
KR100594607B1
(ko)
|
2004-11-03 |
2006-06-30 |
재단법인서울대학교산학협력재단 |
신규한 경구투여용 재조합 인간 성장호르몬 분비미생물제제 및 그 제조방법
|
|
US7998930B2
(en)
|
2004-11-04 |
2011-08-16 |
Hanall Biopharma Co., Ltd. |
Modified growth hormones
|
|
CN101111516B
(zh)
*
|
2005-01-25 |
2013-02-27 |
细胞治疗学公司 |
体内半衰期改变的生物活性蛋白质偶联物
|
|
NZ556726A
(en)
*
|
2005-01-25 |
2011-04-29 |
Cell Therapeutics Inc |
Conjugates of biologically active proteins having a modified in vivo half-life
|
|
WO2006079641A2
(en)
|
2005-01-27 |
2006-08-03 |
Novo Nordisk A/S |
Insulin derivatives conjugated with structurally well defined branched polymers
|
|
AU2006215566A1
(en)
|
2005-02-16 |
2006-08-24 |
Novo Nordisk A/S |
Insulinotropic agents conjugated with structurally well defined branched polymers
|
|
KR100754667B1
(ko)
|
2005-04-08 |
2007-09-03 |
한미약품 주식회사 |
비펩타이드성 중합체로 개질된 면역글로불린 Ｆｃ 단편 및이를 포함하는 약제학적 조성물
|
|
US8008443B2
(en)
|
2005-04-26 |
2011-08-30 |
Medimmune, Llc |
Modulation of antibody effector function by hinge domain engineering
|
|
US8008453B2
(en)
|
2005-08-12 |
2011-08-30 |
Amgen Inc. |
Modified Fc molecules
|
|
US7855279B2
(en)
|
2005-09-27 |
2010-12-21 |
Amunix Operating, Inc. |
Unstructured recombinant polymers and uses thereof
|
|
AU2006324488B2
(en)
|
2005-12-12 |
2013-03-21 |
Abcam Limited |
Production of conjugates
|
|
JP2009525946A
(ja)
|
2005-12-20 |
2009-07-16 |
デューク・ユニヴァーシティ |
増強された薬理学的性質を有する活性物質を送達するための方法および組成物
|
|
DK2402754T4
(da)
|
2006-03-06 |
2023-08-28 |
Amunix Operating Inc |
Ustrukturerede rekombinante polymerer og anvendelser deraf
|
|
US9505823B2
(en)
|
2006-08-07 |
2016-11-29 |
TEV A Biopharmaceuticals USA, Inc. |
Albumin-insulin fusion proteins
|
|
WO2008052108A2
(en)
|
2006-10-26 |
2008-05-02 |
Centocor Ortho Biotech Inc. |
Methods for use in human-adapting monoclonal antibodies
|
|
WO2008049711A1
(en)
|
2006-10-27 |
2008-05-02 |
Novo Nordisk A/S |
Peptide extended insulins
|
|
US20100303723A1
(en)
|
2006-11-20 |
2010-12-02 |
Massachusetts Institute Of Technology |
Drug delivery systems using fc fragments
|
|
WO2008092117A2
(en)
|
2007-01-25 |
2008-07-31 |
Xencor, Inc. |
Immunoglobulins with modifications in the fcr binding region
|
|
KR20080095141A
(ko)
|
2007-04-23 |
2008-10-28 |
포항공과대학교 산학협력단 |
인간 알부민 링커를 통하여 면역글로불린의 Ｆｃ에 결합된생리학적 활성 폴리펩티드의 융합 폴리펩티드, 및 이의제조방법
|
|
KR100897938B1
(ko)
|
2007-05-30 |
2009-05-18 |
주식회사 제넥신 |
면역글로불린 융합 단백질
|
|
JP6071165B2
(ja)
|
2007-05-31 |
2017-02-01 |
ゲンマブ エー／エス |
安定なＩｇＧ４抗体
|
|
WO2009015345A1
(en)
|
2007-07-25 |
2009-01-29 |
Amgen Inc. |
Pharmaceutical compositions comprising fc fusion proteins
|
|
MX2010001684A
(es)
|
2007-08-15 |
2010-04-21 |
Amunix Inc |
Composiciones y metodos para modificar propiedades de polipeptidos biologicamente activos.
|
|
AU2008314697B2
(en)
|
2007-10-22 |
2013-08-29 |
Merck Serono S.A. |
Single IFN-beta fused to a mutated lgG Fc fragment
|
|
KR20170116193A
(ko)
|
2008-06-20 |
2017-10-18 |
노파르티스 아게 |
응집이 감소된 면역글로불린
|
|
US20110119848A1
(en)
|
2008-07-02 |
2011-05-26 |
Koninklijke Philips Electronics N.V. |
V-spring configuration and end attachment assemblies therefor for use in a personal care appliance
|
|
TWI388570B
(zh)
|
2008-07-23 |
2013-03-11 |
韓美科學有限公司 |
包含具有三個官能端的非肽醯聚合物的多肽複合物
|
|
CN108530543B
(zh)
*
|
2009-02-03 |
2023-06-23 |
阿穆尼克斯制药公司 |
延伸重组多肽和包含该延伸重组多肽的组合物
|
|
GB0914110D0
(en)
|
2009-08-12 |
2009-09-16 |
Medical Res Council |
Peptide libraries
|
|
SG10201406063XA
(en)
*
|
2009-09-30 |
2014-11-27 |
Glaxo Group Ltd |
Drug fusions and conjugates with extended half life
|
|
AU2010318542B2
(en)
|
2009-10-29 |
2015-08-27 |
Janssen Biotech Inc. |
Antibody glycosylation variants
|
|
US8637637B2
(en)
|
2010-01-12 |
2014-01-28 |
Bill Nai-Chau Sun |
Fc fusion proteins of human growth hormone
|
|
AR081066A1
(es)
|
2010-04-02 |
2012-06-06 |
Hanmi Holdings Co Ltd |
Conjugado de insulina donde se usa un fragmento de inmunoglobulina
|
|
MX338914B
(es)
|
2010-05-21 |
2016-05-06 |
Xl Protein Gmbh |
Polipeptidos biosinteticos de espira aleatoria de prolina/alanina y sus usos.
|
|
KR101337797B1
(ko)
|
2010-07-14 |
2013-12-06 |
한미사이언스 주식회사 |
지속형 인간 성장 호르몬 결합체 액상 제제
|
|
EP2694528A1
(en)
|
2011-04-05 |
2014-02-12 |
Martin-Protean, LLC |
Isolation of cysteine containing peptides
|
|
UA117901C2
(uk)
|
2011-07-06 |
2018-10-25 |
Ґенмаб Б.В. |
Спосіб посилення ефекторної функції вихідного поліпептиду, його варіанти та їх застосування
|
|
CA2865578C
(en)
|
2012-02-27 |
2023-01-17 |
Amunix Operating Inc. |
Xten conjugate compositions and methods of making same
|
|
JP6290187B2
(ja)
|
2012-05-11 |
2018-03-07 |
クランツ，アレクサンダー |
癌の処置のためのタンパク質の部位特異的標識及び標的送達
|
|
US20160115216A1
(en)
|
2013-06-07 |
2016-04-28 |
Novo Nordisk A/S |
Method for Making Mature Insulin Polypeptides
|
|
AU2014318579A1
(en)
|
2013-09-13 |
2016-04-14 |
The California Institute For Biomedical Research |
Modified therapeutic agents and compositions thereof
|
|
JP6620094B2
(ja)
|
2013-11-26 |
2019-12-11 |
ザ ブリガム アンド ウィメンズ ホスピタル インコーポレイテッドＴｈｅ Ｂｒｉｇｈａｍ ａｎｄ Ｗｏｍｅｎ’ｓ Ｈｏｓｐｉｔａｌ， Ｉｎｃ． |
免疫応答を調節するための組成物および方法
|
|
RU2016139006A
(ru)
|
2014-03-05 |
2018-04-05 |
Юсб Биофарма Спрл |
Мультимерные fc-белки
|
|
CN106687482B
(zh)
|
2014-09-17 |
2022-01-25 |
诺和诺德股份有限公司 |
能够结合组织因子途径抑制剂(1-161)上的两个表位的抗体
|
|
JP2018508504A
(ja)
|
2015-02-17 |
2018-03-29 |
ハンミ ファーマシューティカル カンパニー リミテッド |
持続型インスリンまたはインスリンアナログ結合体
|
|
AR105616A1
(es)
|
2015-05-07 |
2017-10-25 |
Lilly Co Eli |
Proteínas de fusión
|
|
CN107743494B
(zh)
|
2015-06-02 |
2022-04-29 |
诺和诺德股份有限公司 |
具有极性重组延伸体的胰岛素
|
|
HUE057906T2
(hu)
|
2015-08-14 |
2022-07-28 |
Remegen Biosciences Inc |
Kovalens kötõcsoportok ellenanyag-hatóanyag konjugátumokban és eljárások elõállításukra és alkalmazásukra
|
|
EP3355931B1
(en)
|
2015-10-01 |
2024-06-26 |
Novo Nordisk A/S |
Protein conjugates
|
|
MA49339A
(fr)
|
2017-04-05 |
2020-02-12 |
Novo Nordisk As |
Conjugués insuline-fc à extension oligomère
|